Table: RaQualia Pharma -Q1 group results
May 12 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2017 Mar 31, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 417 mln 1.18
Operating loss 59 mln loss 791 mln
Recurring loss 74 mln loss 777 mln
Net loss 65 mln loss 778 mln
EPS loss 3.44 yen loss 40.45 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))